Ansimar ® [tab]

Contents Doxofylline
Indications Bronchial asthma & pulmonary disease w/ spastic bronchial
component.
Dosage Tab Adult 1 tab bid-tid. Syr Childn >12 yr 10 mL once-tid,
<12 yr 6-9 mg/kg bid.
Administration May be taken with or without food
Contraindications Acute MI, hypotension, lactation.
Special Liver disease, CHF, chronic obstructive lung disease,
Precautions concomitant infections. Pregnancy.
Adverse Drug Nausea, vomiting, epigastric pain, cephalalgia, irritability,
Reactions insomnia, tachycardia, extrasystole, tachypnea,
hyperglycemia, albuminuria.
Click to view ADR Monitoring Website
Drug Interactions Erythromycin, troleandomycin, lincomycin, clindamycin,
allopurinol, cimetidine, propranolol, anti-flu vaccine,
xanthines.
Click here for more Interaction Checks
Storage For special storage condition to ensure optimal shelf-life of
medicine... click to view
Mechanism of For Details of the mechanism of action, pharmacodynamics
Action and pharmacokinetics ... click to view
MIMS Class Antiasthmatic & COPD Preparations
ATC R03DA11 - Doxofylline ; Belongs to the class of other
Classification systemic drugs used in the treatment of obstructive airway
diseases, xanthines.
Poison Schedule Rx
Packing/Presentation
Form Packing/Price Photo
Ansimar syrup Ansimar 100 mg/5 mL x 100 mL (P282.24)
 Ansimar 400 mg x 50's
Ansimar tablet
(P1750.25)